Search | IOVS | ARVO Journals

Showing 1 – 20 of 62

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Vessel density metrics using swept-source OCTA discriminates severity staging in advanced NPDR: The CHART Study

Conceicão Lobo; Inês Marques; Torcato Santos; Débora Reste-Ferreira; Mariacristina Parravano; Catherine P Creuzot Garcher; Leonardo Mastropasqua; Francesco Bandello; José Cunha-Vaz

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5517.

ARVO Annual Meeting Abstract June 2024

Loss of complex gangliosides does not affect retinal structure and function in mice

Elodie AY Masson; Lucy Martine; Hatice Adsiz; Bénédicte Buteau; Elisabeth Dubus; Stéphanie Cabaret; Olivier Berdeaux; Lionel Bretillon; Alain M. Bron; Catherine P Creuzot Garcher; Pierre-Henry Gabrielle; Niyazi Acar

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1691.

ARVO Annual Meeting Abstract June 2024

Blood lipidomics in age-related macular degeneration: insights into phospholipids, cholesteryl esters and n-3 polyunsaturated fatty acid supplementation

Niyazi Acar; Glenda Vasku; Elisabeth Dubus; Caroline Peltier; Stéphanie Cabaret; Stéphane Grégoire; Lucy Martine; Victoire Hurand; Alain M. Bron; Catherine P Creuzot Garcher; Pierre-Henry Gabrielle; Olivier Berdeaux

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3167.

ARVO Annual Meeting Abstract June 2024

Efficacy and Safety of Fluocinolone Acetonide Implant (Iluvien®) in Postoperative Cystoid Macular Edema: ILUCYD study

Karolina Motloch; Aude Couturier; Marie-Noëlle DELYFER; Vivien Vasseur; Benjamin Wolff; Mohamad Issa; Corinne Dot; Michel Weber; Alban Comet; Wolfgang Hitzl; Catherine P Creuzot Garcher; Laurent Kodjikian; Ramin Tadayoni

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4412.

ARVO Annual Meeting Abstract June 2021

COVID-19 pandemic lockdown international impact on nAMD, DME and RVO intravitreal therapy outcomes: Fight Retinal Blindness International registry

Javier Zarranz-Ventura; Vuong Nguyen; Catherine P Creuzot Garcher; Frank D Verbraak; Louise OToole; Alessandro Invernizzi; Francesco Viola; David Squirrell; Daniel Barthelmes; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):311.

ARVO Annual Meeting Abstract June 2020

Epidemiology of acute endophthalmitis after ophthalmological procedures, a national database description

Florian BAUDIN; Eric Benzenine; Anne-Sophie Mariet; Alain M Bron; Catherine Quantin; Catherine P Creuzot Garcher

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2307.

ARVO Annual Meeting Abstract June 2020

Novel missense mutations in PRPF6 cause autosomal dominant retinitis pigmentosa with incomplete penetrance and impairment of PRPF6 protein localization within the nucleus

Guillaume OLIVIER; Beatrice BOCQUET; Carlo Rivolta; Ervann Andreo; Agnes Muller; Christian Hamel; Alice MASUREL; Catherine P Creuzot Garcher; Laurence FAIVRE; Isabelle Anne Meunier; Gael Manes

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2401.

ARVO Annual Meeting Abstract June 2020

Association between anatomical and clinical outcomes in patients treated with anti-vascular endothelial growth factor for neovascular age-related macular degeneration

Mark C Gillies; Vuong Nguyen; Calvo Pilar; Martin Puzo; Pierre-Henry GABRIELLE; Catherine P Creuzot Garcher; Florian Baudin; Benjamin Wolff; Louise O’ Toole; Laurent Castelnovo; Michel Guillaume; Daniel Barthelmes

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4214.

ARVO Annual Meeting Abstract June 2020

Ranibizumab or Aflibercept for Diabetic Macular Edema: One-Year Comparison of Real-World Outcomes from Fight Retinal Blindness! Registry.

SANJEEB BHANDARI; Vuong Nguyen; Samantha Fraser-Bell; Hemal Mehta; Francesco Viola; Florian Baudin; Pierre-Henry Gabrielle; Catherine P Creuzot Garcher; Mark C Gillies; Daniel Barthelmes

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3289.

ARVO Annual Meeting Abstract July 2018

Development and validation of a risk-prediction nomogram for poor functional response one year after treatment with anti-VEGF in naive-diabetic macular edema.

Pierre-Henry GABRIELLE; Jacques Bouche-Pillon; Edouard Maupin; Serge Aho-Glele; Ramin Tadayoni; Laurent Kodjikian; Alain M Bron; Pascale Massin; Catherine P Creuzot Garcher

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3615.

ARVO Annual Meeting Abstract July 2018

Quantitative metrics in Swept Source-Optical Coherence Tomography in healthy eyes: fractal dimension, an interesting tool?

Louis Arnould; Pierre-Henry GABRIELLE; Florian Baudin; Behzad Aliahmad; Marc Sarossy; Alain M Bron; Catherine P Creuzot Garcher

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2885.

ARVO Annual Meeting Abstract June 2017

A Pharmacoepidemiological study of intravitreal drug consumption in the first 12 months of treatment. The EPIdemiology and SAFEty collaboration.

Vincent Daien; Catherine P Creuzot Garcher; Marie-Noëlle Delyfer; Alain M Bron; Mark C Gillies; Sandy Lacombe; Laurence Papinaud; Dominique Cholley; Caroline Domerg; Audrey Cougnard-Gregoire; Catherine Quantin; Max Villain; Jean Pierre Daures; Cecile DelCourt; Jean-Francois Korobelnik

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):902.

ARVO Annual Meeting Abstract June 2017

Role of 24-S-hydroxycholesterol in membrane dynamics during retinal gliosis in glaucoma.

Pierre-Henry GABRIELLE; Ségolène Gambert; Lionel Bretillon; Alain M Bron; Catherine P Creuzot Garcher

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5385.

ARVO Annual Meeting Abstract June 2017

Real-world outcomes with ranibizumab 0.5 mg treatment in French patients with visual impairment due to diabetic macular edema: 12-month results from the 36-month BOREAL-DME study

Catherine P Creuzot Garcher; Pascale Massin; Laurent KODJIKIAN; Jean-Francois Girmens; Cecile DelCourt; Frank Fajnkuchen; Agnès Glacet; Pierre-Jean Guillausseau; Audrey Derveloy; Laetitia FINZI; Patrick Blin; BPE Team

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1915.

ARVO Annual Meeting Abstract June 2017

Real-world outcomes with ranibizumab 0.5 mg treatment in French patients with visual impairment due to macular edema secondary to central retinal vein occlusion: 6-month results from the 24-month BOREAL-CRVO study

Mayer Srour; Agnès Glacet; Jean-Francois Girmens; Laurent KODJIKIAN; Cecile DelCourt; Frank Fajnkuchen; Catherine P Creuzot Garcher; Pascale Massin; Pierre-Jean Guillausseau; Anne Ponthieux; Laetitia FINZI; Angela Grelaud-Boussinot; BPE Team

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4630.

ARVO Annual Meeting Abstract June 2017

A pro-diabetic diet triggers early functional and structural changes in the rat retina

Elisa Vidal; Elise Lalarme; Laurence Decocq; Marie-Annick Maire; Jeannine Lherminier; Magalie Thierry; Alain M Bron; Catherine P Creuzot Garcher; Niyazi Acar; Lionel Bretillon

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5867.

ARVO Annual Meeting Abstract September 2016

Ranibizumab in patients with neovascular age-related macular degeneration in real-world clinical settings in France: 1-year data from the LUMINOUS™ study

Vittorio Capuano; OUBRAHAM-MEBROUKINE Hassiba; Benjamin Wolff; Salomon Y Cohen; Catherine P Garcher; Jean-Francois Korobelnik; Ramin Tadayoni; Christian Delhay; Audrey Derveloy; Eric H Souied

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):534.

ARVO Annual Meeting Abstract September 2016

Cholesterol homeostasis and retinal stress in anterior ischemic optic neuropathy

Lionel Bretillon; Cynthia Fourgeux; Jacques Bouche-Pillon; Lucy Martine; Laurent Leclere; Niyazi Acar; Alain M Bron; Catherine P Garcher

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):109.

ARVO Annual Meeting Abstract September 2016

Functional and anatomical outcomes after successful macula-off retinal detachment surgery, a 12 month-follow-up.

Clémence DESCHASSE; Yann Kauffmann; Mathilde Frerot; Alain M Bron; Catherine P Garcher

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1047.

ARVO Annual Meeting Abstract September 2016

Anatomical and functional outcomes one year after macular hole surgery.

Louis Arnould; Yann Kauffmann; Abderrahmane Bourredjem; Christine Binquet; Alain M Bron; Catherine P Garcher

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2053.

1 2 3 4

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Vessel density metrics using swept-source OCTA discriminates severity staging in advanced NPDR: The CHART Study

Loss of complex gangliosides does not affect retinal structure and function in mice

Blood lipidomics in age-related macular degeneration: insights into phospholipids, cholesteryl esters and n-3 polyunsaturated fatty acid supplementation

Efficacy and Safety of Fluocinolone Acetonide Implant (Iluvien®) in Postoperative Cystoid Macular Edema: ILUCYD study

COVID-19 pandemic lockdown international impact on nAMD, DME and RVO intravitreal therapy outcomes: Fight Retinal Blindness International registry

Epidemiology of acute endophthalmitis after ophthalmological procedures, a national database description

Novel missense mutations in PRPF6 cause autosomal dominant retinitis pigmentosa with incomplete penetrance and impairment of PRPF6 protein localization within the nucleus

Association between anatomical and clinical outcomes in patients treated with anti-vascular endothelial growth factor for neovascular age-related macular degeneration

Ranibizumab or Aflibercept for Diabetic Macular Edema: One-Year Comparison of Real-World Outcomes from Fight Retinal Blindness! Registry.

Development and validation of a risk-prediction nomogram for poor functional response one year after treatment with anti-VEGF in naive-diabetic macular edema.

Quantitative metrics in Swept Source-Optical Coherence Tomography in healthy eyes: fractal dimension, an interesting tool?

A Pharmacoepidemiological study of intravitreal drug consumption in the first 12 months of treatment. The EPIdemiology and SAFEty collaboration.

Role of 24-S-hydroxycholesterol in membrane dynamics during retinal gliosis in glaucoma.

Real-world outcomes with ranibizumab 0.5 mg treatment in French patients with visual impairment due to diabetic macular edema: 12-month results from the 36-month BOREAL-DME study

Real-world outcomes with ranibizumab 0.5 mg treatment in French patients with visual impairment due to macular edema secondary to central retinal vein occlusion: 6-month results from the 24-month BOREAL-CRVO study

A pro-diabetic diet triggers early functional and structural changes in the rat retina

Ranibizumab in patients with neovascular age-related macular degeneration in real-world clinical settings in France: 1-year data from the LUMINOUS™ study

Cholesterol homeostasis and retinal stress in anterior ischemic optic neuropathy

Functional and anatomical outcomes after successful macula-off retinal detachment surgery, a 12 month-follow-up.

Anatomical and functional outcomes one year after macular hole surgery.

To View More...

You must be signed into an individual account to use this feature.